Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences
  • Register
  • Login

Urology Journal

  • Home
  • Instant Online
    • Instant 2026
    • Instant 2023
    • Instant 2021
    • Instant 2020
  • Current
  • Archives
  • Announcements
  • Submissions
  • Author Guidelines
  • About
    • About the Journal
    • Editorial Team
    • Privacy Statement
    • Contact
Advanced Search
  1. Home
  2. Archives
  3. Vol. 15 No. 3 (2018): May-June2018
  4. ORIGINAL PAPER (ENDOUROLOGY AND STONE DISEASE)

Vol. 15 No. 3 (2018)

May 2018

Quantitative Mineralogical Composition of Calculi and Urine Abnormalities for Calcium Oxalate Stone Formers: A Single-Center Results

  • Andrey V. Kustov
  • Alexander I. Strelnikov

Urology Journal, Vol. 15 No. 3 (2018), 3 May 2018 , Page 87-91
https://doi.org/10.22037/uj.v15i3.3910 Published: 2018-05-03

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Purpose: The paper focuses on the relationship of risk factors and metabolic disorders with mineralogical composition of calculi, age and gender of calcium oxalate stone formers.
Materials and Methods: Stone mineralogical composition, 24 hour biochemistry and pH-profile of urine were examined for sixty four stone formers using powder X-ray diffraction, spectrophotometric and potentiometric techniques.
Results: The analysis indicated that 44 % of calculi were composed of pure calcium oxalate monohydrate, whereas other 56 % contained both monohydrate and dihydrate or usually their mixtures with hydroxyl apatite. Hypocitraturia, hypercalciuria and hyperuricosuria were identified as the most frequent disorders. Patients with pure calcium oxalate stones and calcium oxalate mixed with apatite revealed different patterns including age, acid-base balance of urine, calcium, citrate excretion etc.
Conclusions: Our results demonstrate that most patients simultaneously reveal several risk factors. The special attention should be paid to normalize the daily citrate, calcium and urate excretion. High risk patients, such as postmenopausal females or stone formers with a high apatite content require a specific metabolic evaluation towards in highlighting abnormalities associated with stone formation.
  • PDF

How to Cite

Kustov, A. V., & Strelnikov, A. I. (2018). Quantitative Mineralogical Composition of Calculi and Urine Abnormalities for Calcium Oxalate Stone Formers: A Single-Center Results. Urology Journal, 15(3), 87–91. https://doi.org/10.22037/uj.v15i3.3910
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Daudon M, Bazin D, Andre G, et al. Examination of whewellite kidney stones by scanning electron microscopy and powder neutron diffraction techniques. J Appl Cryst. 2009; 42: 109-15.

Schubert G. Urinary stone analysis. In: Rao PN, Preminger GN and Kavanagh JP, editors. Urinary Tract Stone Disease. London: Springer-Verlag; 2011. p. 341-53.

Wu W, Yang D, Tiselius H.-G, et al. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results. Urology 2014;83: 732-7.

Ansari MS, Gupta NP, Hemal AH, et al. Spectrum of stone composition: structural analysis of 1050 upper urinary tract calculi from northern India. Int J Urol. 2005; 12: 12–6.

Laurence ME, Levillain P, Lacour B, Daudon M. Advantage of zero-crossing-point first-derivative spectrophotometry for the quantification of calcium oxalate crystalline phases by infrared spectrophotometry. Clin

Chim Acta 2000; 298: 1-11.

Hess B. Urinary citrate and citrate metabolism. In: Rao PN, Preminger GN and Kavanagh JP, editors. Urinary Tract Stone Disease. London:

Springer-Verlag; 2011. p. 181-4.

Caudarella R, Vescini F, Buffa A, Stefoni S. Citrate and mineral metabolism: kidney stones and bone disease. Front Bioscience 2003; 8:

-106.

Trinchieri A, Castelnuovo Ch, Lizzano R, Zanetti G. Calcium stone disease: a multiform reality. Urol Res. 2005; 33:194-8.

Bichler KH, Lahme C, Mattauch W, Strohmaier WL. Metabolische evaluation und metaphylaxe von harnsteinpatienten. Aktuel Urol. 2000; 31: 283-93.

Preminger GM, Tan YH: Pharmacologic prophylaxis of calcium stones. In: Stoller ML and Meng MV, editors. Urinary stone disease: the practical guide to medical and surgical management. New Jersey: Humana Press;

p. 269-84.

Tiselius H.-G. Risk formulas in calcium oxalate urolithiasis. W J Urol. 1997; 15:176-85.

Straub M., Strohmaier WL, Berg W, et al. Diagnosis and metaphylaxis of stone disease. Consensus concept of the national working committee on stone disease for the upcoming German urolithiasis guideline. W J Urol.

; 23:309-23.

Bazin D, Leroy C, Tielens F, et al. Hyperoxaluria is related to whewellite and hypercalciuria to weddellite: what happens when crystalline conversion occurs? C R Chimie 2016; 19:1492-503.

Pak CYC. Citrate and renal calculi: an update. Miner Elect Metab. 1994; 20: 371-377.

Grases F., Sanchis P., Perello J., Costa-Bauzá A. Role of uric acid in different types of calcium oxalate renal calculi. Int J Urol. 2006;

:252–6.

Kustov AV, Strelnikov AI, Airapetyan AO, Kheiderov ShM. New step-by-step algorithms for diagnosis of calcium oxalate urolithiasis based on a qualitative mineralogical composition of calculi. Clin Neph & Urol Sci

; 2:3.

Odvina CV, Pak CYC. Medical evaluation of stone disease. In: Stoller ML and Meng MV, editors. Urinary stone disease: the practical guide to medical and surgical management. New Jersey: Humana Press; 2007. p. 258-68.

  • Abstract Viewed: 1056 times
  • PDF Downloaded: 507 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Information

  • For Readers
  • For Authors

Developed By

Open Journal Systems
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact
Powered by OJSPlus